retatrutide and tirzepatide vs Tirzepatide: Triple vs Dual Agonist Retatrutide vs Tirzepatide: Best Triple

Ready to give tirzepatide a try

Case series: We present a long-term follow-up of treatment with GLP-1 receptor agonist (GLP-1 RA) semaglutide in three patients with PWS without diabetes, one of whom had previously undergone metabolic surgery

Dehydration can exacerbate musculoskeletal discomfort and potentially lead to kidney problems

These findings translate to clinical research, as increased insulin resistance in patients with PD has been related to the severity of non-motor symptoms [155]

Tirzepatide maintenance dosing in these patients often remains at 1015mg weekly because the metabolic resistance is profound and permanent

Both are excellent options, and the choice may depend on your specific cardiovascular risk profile